As the global economy mends, the 2021 growth of Sodium Aescinate will have significant change from previous year. According to our (LP Information) latest study, the global Sodium Aescinate market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Sodium Aescinate market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Sodium Aescinate market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Sodium Aescinate market, reaching US$ million by the year 2028. As for the Europe Sodium Aescinate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Sodium Aescinate players cover Baxter Laboratories, Hospira, American Regent, and Fujisawa Canada, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Sodium Aescinate market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Injection
Tablets
Gel
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Operation Center
Outpatient Service
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Baxter Laboratories
Hospira
American Regent
Fujisawa Canada
Sabex
Fresenius Kabi
Omega Laboratories
Clintec Nutrition Company
Beijing Sihuan Kebao Pharmaceutical
Shandong Lvye Pharmaceutical
Guangdong Xinghao Pharmaceutical
Wuxi Kaifu Pharmaceutical
Wuhan Pusheng Pharmaceutical
Wuhan Aimin Pharmaceutical
Wuhan Changlian Laifu Pharmaceutical
Hunan Yige Pharmaceutical
Fujian Mindong Lijiexun Pharmaceutical
Chongqing Huasen Pharmaceutical
Heilongjiang Dilong Pharmaceutical